US · BSTZ
BlackRock Science and Technology Trust II
- Sector
- Financial Services · Asset Management
- Headquarters
- New York City, NY 10055
- Website
- blackrock.com
Price · as of 2024-12-31
$26.97
Market cap 1.56B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $287.29 | +965.22% |
| Intrinsic Value(DCF) | $24.21 | -10.23% |
| Graham-Dodd Method(GD) | $34.62 | +28.37% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $11.01 | ||||
| 2020 | $20.87 | $98.24 | $38.08 | $124.13 | $0.00 |
| 2021 | $16.43 | $147.87 | $0.00 | $17.39 | $3,959.92 |
| 2022 | $11.93 | $34.24 | $0.00 | $0.00 | $1,065.49 |
| 2023 | $15.05 | $111.52 | $0.00 | $35.63 | $0.00 |
| 2024 | $16.60 | $287.29 | $29.28 | $34.62 |
AI valuation
Our deep-learning model estimates BlackRock Science and Technology Trust II's (BSTZ) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $287.29
- Current price
- $26.97
- AI upside
- +965.22%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$24.21
-10.23% upside
Graham-Dodd
$34.62
+28.37% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| BSTZ | BlackRock Science and Tec… | $26.97 | 1.56B | +965% | -10% | +28% | — | 2.11 | 0.42 | 2.10 | 2.10 | — | 0.42 | 100.00% | 99.31% | 99.31% | 21.18% | 21.23% | 16.22% | 0.01 | 77771.91 | — | — | 0.03 | -892.00% | -89891.00% | -37398.00% | 16.36% | — | 7.34% | 17.82% | 37.60% | 17.82% | 2.10 | 6.09 | 2.09 | 14.97 |
| BCAT | BlackRock Capital Allocat… | $15.18 | 1.59B | +105% | — | — | — | 6.66 | 0.75 | 6.55 | — | 236.94 | 0.75 | 100.00% | 98.35% | 98.35% | 10.88% | 10.92% | 9.79% | 0.00 | 138.47 | — | — | — | 281.00% | -446.00% | 9572.00% | 27.43% | — | 19.93% | 21.75% | 144.80% | 25.26% | 6.62 | 3.63 | 6.51 | 4.26 |
| BDJ | BlackRock Enhanced Equity… | $9.67 | 1.71B | +165% | -17% | -68% | — | 8.55 | 0.88 | 30.09 | — | 57.70 | 0.88 | 100.00% | 68.30% | 352.03% | 10.18% | 2.00% | 10.01% | 0.00 | 7848.88 | 2.88 | 3.01 | — | 1481.00% | -6910.00% | 5166.00% | 14.88% | 12.95 | 13.13% | 8.89% | 76.00% | 14.89% | 42.60 | 6.50 | 29.10 | 52.65 |
| BTT | Blackrock Municipal 2030 … | $22.94 | 1.47B | +18% | -38% | -16% | -77% | 26.22 | 0.92 | 17.30 | — | 132.97 | 0.92 | 100.00% | 80.19% | 65.99% | 3.50% | 2.82% | 2.27% | 0.54 | — | 0.23 | 0.42 | — | 1972.00% | -205.00% | -5598.00% | 4.24% | 0.61 | 2.58% | 2.74% | 72.00% | 5.22% | 33.87 | 37.05 | 27.16 | 1.09 |
| ECAT | BlackRock ESG Capital All… | $15.14 | 1.5B | +98% | — | — | — | 5.62 | 0.77 | 5.52 | — | — | 0.77 | 100.00% | 98.36% | 98.36% | 13.43% | 13.46% | 12.42% | 0.00 | 180898.81 | — | — | — | -1856.00% | -1777.00% | 10436.00% | 25.05% | — | 18.93% | 21.34% | 119.90% | 24.79% | 5.60 | 3.98 | 5.51 | 6.01 |
| GDV | The Gabelli Dividend & In… | $28.87 | 2.56B | +66% | -69% | -5% | +1,663% | 6.75 | 0.76 | 6.52 | 7.51 | 35.93 | 0.76 | 100.00% | 99.42% | 99.42% | 11.61% | 11.01% | 10.68% | 0.11 | 42.70 | 0.01 | 2.34 | 0.96 | 1879.00% | 14577.00% | -10053.00% | -0.03% | -0.29 | -0.03% | 5.78% | 39.00% | 6.78% | 7.52 | -3275.01 | 7.47 | 5.04 |
About BlackRock Science and Technology Trust II
BlackRock Science and Technology Term Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating in the science and technology sectors. It primarily invests in growth stocks of companies across all market capitalizations. BlackRock Science and Technology Term Trust was formed in June 2019 and is domiciled in the United States.
- CEO
- John M. Perlowski
- Employees
- 0
- Beta
- 1.43
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($24.21 ÷ $26.97) − 1 = -10.23% (DCF, example).